Artemin Antibody [Unconjugated]

• Reactivity: Hu
• Applications: WB, IHC
• Clonality: Polyclonal
• Host: Goat
• Conjugate: Unconjugated
• Concentration: LYOPH

Artemin Antibody [Unconjugated] Summary

• Immunogen: E. coli-derived recombinant human Artemin
  Ala108-Gly220
  Accession # Q5T4W7
• Specificity: Detects human Artemin in direct ELISAs and Western blots. In direct ELISAs, approximately 50% cross-reactivity with recombinant mouse Artemin is observed.
• Source: N/A
• Isotype: IgG
• Clonality: Polyclonal
• Host: Goat
• Gene: ARTN
• Purity Statement: Antigen Affinity-purified

Applications/Dilutions

• Dilutions:
  • Immunohistochemistry 5-15 ug/mL
  • Western Blot 0.1 ug/mL

Packaging, Storage & Formulations

• Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
• Preservative: No Preservative
• Concentration: LYOPH
• Reconstitution Instructions: Reconstitute at 0.2 mg/mL in sterile PBS.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Artemin Antibody [Unconjugated]

• Artemin
• ARTN
• Enovin
• EVN
• EVNneurotrophic factor
• NBN
• Neublastin

Background

Human Artemin (ARTN; also known as enovin and neublastin) is a GDNF family ligand that is distantly related to the TGF-beta superfamily of molecules (1‑4). As such, it is synthesized as a preproprotein, and contains a variable length pre-, or signal sequence, plus a 68 amino acid (aa) proregion and a 113 aa mature segment (5‑7). Alternate splicing and start sites create signal sequences of 22, 30 and 39 aa, respectively. Their significance is unknown. Following synthesis and proteolytic processing, mature ARTN is secreted as a presumably glycosylated, 28 kDa disulfide-linked homodimer that contains three intrachain disulfide bonds and the typical TGF-beta signature cysteine-knot motif (5, 7). In the mature region, human ARTN is 89% and 88% aa identical to rat (8) and mouse ARTN (5, 7), respectively. Cells known to express ARTN include Schwann cells (2) and embryonic vascular smooth muscle cells (9). Human ARTN is active on rodent cells (5). The receptor for ARTN has been identified as the ligand binding subunit GFR alpha -3 plus the signal transducing subunit, RET (1, 5). The GFR alpha -1/RET receptor complex has also been suggested to be a ligand binding unit for ARTN (2, 5). Evidence, however, suggests that the GFR alpha -1/RET complex plays no functional role in ARTN activity (10, 11). ARTN is known to be a chemoattractant for sympathetic neuron axons innervating the developing cardiovascular system (9). It also promotes sensory neuron survival and likely plays a role in the development of the peripheral nervous system (5). Finally, it has been reported to reverse neuropathic pain due to nerve injury, and to help resolve morphological changes associated with nerve damage (12).

1. Airaksinen, M.S. and M. Saarma (2002) Nat. Rev. Neurosci. 3:383. 
2. Saarma, M. (2000) Eur. J. Biochem. 267:6968. 
3. Sariola, H. et al. (2003) J. Cell Sci. 116:3855. 
4. Chang, H. et al. (2002) Endocr. Rev. 23:787. 
5. Baloh, R.H. et al. (1998) Neuron 21:1291. 
6. Masure, S. et al. (1999) Eur. J. Biochem. 266:892. 
7. Rosenblad, C. et al. (2000) Mol. Cell. Neurosci. 15:199.
8. Stover, T. et al. (2000) Brain Res. Mol. Brain Res. 76:25.
9. Honma, Y. et al. (2002) Neuron 35:267.
10. Rakowicz, W.P. et al. (2002) J. Neurosci. 22:3953.
11. Carmillo, P. et al. (2005) Biochemistry 44:2545.
12. Gardell, L.R. et al. (2003) Nat. Med. 9:1383.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Publications for Artemin Antibody (AF2589)(4)

Publications using AF2589

• Banerjee , Arindam, Wu , Zheng-Sh, Qian , Peng-Xu, Kang , Jian, Liu , Dong-Xu, Zhu , Tao, Lobie , Peter E ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling. PLoS ONE, 2012-11-21;7(11):e50098. 2012-11-21 [PMID: 23185544] (Western Blot, Human)
• Kang J, Qian PX, Pandey V Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma. Oncogene, 2010-03-22;29(22):3228-40. 2010-03-22 [PMID: 20305694] (Western Blot, Human)
• Pandey V, Qian PX, Kang J, Perry JK, Mitchell MD, Yin Z, Wu ZS, Liu DX, Zhu T, Lobie PE Artemin stimulates oncogenicity and invasiveness of human endometrial carcinoma cells. Endocrinology, 2010-01-29;151(3):909-20. 2010-01-29 [PMID: 20118197] (Western Blot, Human)
• Liu DX, Lobie PE Transcriptional activation of p53 by Pitx1. Cell Death Differ., 2007-08-31;14(11):1893-907. 2007-08-31 [PMID: 17762884] (Immunoprecipitation, Human)

Bioinformatics

• Gene Symbol: ARTN
• Uniprot:
  • Q5T4W7()